NON-HODGKIN LYMPHOMA - FDA approved drugs & results from clinical trials

NON-HODGKIN LYMPHOMA - FDA approved drugs & results from clinical trials

This report is specific for non-Hodgkin's lymphoma

This 47 page report has 9 sections, which includes basic explanation of the disease state, 5-year survival rate, basic outline of current therapeutic approaches, information on 39 FDA approved drugs, outline of the mechanism of action for each drug, outcome of clinical trials measured as response rate, median overall survival and disease progression-free survival, ongoing clinical trials, information on support groups and list of other credible resources to support your own research. 

    $25.00Price
     
    • Facebook
    • Twitter

    ©2021 by CancerTherapies4U LLC     All rights reserved.